RNA sequencing (RNA-seq) is widely used to perform expression analysis of entire transcriptomes with high sensitivity and a wide dynamic range. Despite being a pivotal tool in biomarker discovery, RNA-seq can be challenging if the RNA samples have a low concentration or are degraded. This is common when working with patient-derived samples such as tissue biopsies, blood, or other biofluids.
The SMARTer Stranded Total RNA-Seq Kit v3 – Pico Input Mammalian (referred to as “Pico v3”) is designed for efficient preparation of sequencing libraries from picogram amounts (10 ng–250 pg) of high- or low-quality total RNA (RIN 2–10, DV200 > 25%).
A random priming approach enables whole transcriptome profiling of coding and noncoding RNA biotypes (e.g. mRNA, lncRNAs, lincRNAs, etc.). Unlike a dT priming approach which relies on intact polyA tails, a random priming approach is also ideal for library preparation from degraded samples, including formalin-fixed paraffin-embedded (FFPE) tissue, laser capture microdissection (LCM) samples, and cell-free RNA (cfRNA) from biofluids, serum, plasma, and exosomes.
Using a combination of SMART® (Switching Mechanism at 5’ end of RNA Template) technology with ZapR® innovation for ribosomal cDNA depletion, Pico v3 is a complete solution for ribodepleted, strand-specific libraries with full gene body coverage for information on isoforms, fusions, etc. ZapR technology is a cas9-based post-library depletion technique to effectively deplete rRNA from picogram amounts of total RNA, which plays an essential role in achieving success with low-input amounts of total RNA. Competitor depletion technologies are limited to significantly higher nanogram inputs.
The workflow also incorporates unique molecular identifiers (UMIs) during reverse transcription to mitigate potential PCR errors and amplification biases, enabling quantitative analysis and accurate variant calling, especially for rare mutations.
Biomarker discovery also benefits from faster sequencing turnaround times. Singular Genomics has developed an innovative benchtop sequencer, the G4 Sequencing Platform, that leverages a 4-color rapid sequencing by synthesis (SBS) chemistry with advanced optics and fluidics engineering to provide single-day turnaround times across all applications. By combining fast run times and the ability to run up to 4 flow cells, with 16 independently addressable lanes, G4 delivers accuracy, speed, power, and unprecedented flexibility for a wide range of genomic applications.
Here we expand our existing Pico V3 kit—initially designed for Illumina® sequencing technology—to work seamlessly with other sequencing platforms such as the G4. We show that total RNA libraries prepared with Pico v3 from 10 ng or 0.25 ng of Human Brain Total RNA Control yields similar sequencing metrics and data quality on the Singular Genomics G4 Sequencing Platform as on industry-standard sequencing platforms. These results show that researchers now have access to a fast, accurate, and cost-effective solution to power biomarker discovery from challenging and low input samples.